End-of-day quote
Taiwan S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
14.1
TWD
|
-0.70%
|
|
+0.36%
|
-7.84%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,235
|
1,903
|
2,398
|
5,193
|
2,736
|
2,829
|
Enterprise Value (EV)
1 |
2,741
|
2,660
|
2,165
|
5,812
|
3,227
|
3,374
|
P/E ratio
|
143
x
|
-280
x
|
4.57
x
|
-74.1
x
|
44.8
x
|
-10.2
x
|
Yield
|
-
|
-
|
3.85%
|
-
|
0.68%
|
-
|
Capitalization / Revenue
|
0.65
x
|
0.59
x
|
0.87
x
|
1.82
x
|
0.91
x
|
1.29
x
|
EV / Revenue
|
0.79
x
|
0.82
x
|
0.79
x
|
2.04
x
|
1.07
x
|
1.54
x
|
EV / EBITDA
|
13.6
x
|
10.7
x
|
-1,896
x
|
40.1
x
|
12.2
x
|
-94.2
x
|
EV / FCF
|
-15.8
x
|
-25.8
x
|
3.19
x
|
-7.01
x
|
38.9
x
|
37.5
x
|
FCF Yield
|
-6.34%
|
-3.87%
|
31.3%
|
-14.3%
|
2.57%
|
2.67%
|
Price to Book
|
0.96
x
|
0.84
x
|
0.97
x
|
2.23
x
|
1.14
x
|
1.34
x
|
Nbr of stocks (in thousands)
|
188,995
|
184,474
|
184,474
|
184,474
|
184,884
|
184,884
|
Reference price
2 |
11.82
|
10.32
|
13.00
|
28.15
|
14.80
|
15.30
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/25/21
|
3/30/22
|
3/25/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,452
|
3,244
|
2,753
|
2,851
|
3,009
|
2,186
|
EBITDA
1 |
201.4
|
248.7
|
-1.142
|
145.1
|
265.2
|
-35.82
|
EBIT
1 |
-36.39
|
17.32
|
-243.8
|
-95.95
|
32.56
|
-260
|
Operating Margin
|
-1.05%
|
0.53%
|
-8.86%
|
-3.37%
|
1.08%
|
-11.9%
|
Earnings before Tax (EBT)
1 |
11.86
|
-9.085
|
483.3
|
-53.84
|
71.47
|
-296.2
|
Net income
1 |
16.12
|
-6.808
|
524.4
|
-69.96
|
61.33
|
-278
|
Net margin
|
0.47%
|
-0.21%
|
19.05%
|
-2.45%
|
2.04%
|
-12.72%
|
EPS
2 |
0.0824
|
-0.0369
|
2.847
|
-0.3800
|
0.3300
|
-1.503
|
Free Cash Flow
1 |
-173.8
|
-103
|
678.5
|
-829.3
|
82.92
|
90.09
|
FCF margin
|
-5.03%
|
-3.18%
|
24.65%
|
-29.09%
|
2.76%
|
4.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
31.26%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
129.39%
|
-
|
135.2%
|
-
|
Dividend per Share
|
-
|
-
|
0.5000
|
-
|
0.1000
|
-
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/25/21
|
3/30/22
|
3/25/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
507
|
757
|
-
|
619
|
490
|
545
|
Net Cash position
1 |
-
|
-
|
233
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.515
x
|
3.043
x
|
-
|
4.268
x
|
1.848
x
|
-15.23
x
|
Free Cash Flow
1 |
-174
|
-103
|
679
|
-829
|
82.9
|
90.1
|
ROE (net income / shareholders' equity)
|
0.64%
|
-0.3%
|
22.1%
|
-2.91%
|
2.59%
|
-12.3%
|
ROA (Net income/ Total Assets)
|
-0.55%
|
0.26%
|
-3.37%
|
-1.35%
|
0.49%
|
-4.11%
|
Assets
1 |
-2,957
|
-2,626
|
-15,567
|
5,186
|
12,471
|
6,763
|
Book Value Per Share
2 |
12.30
|
12.30
|
13.40
|
12.60
|
13.00
|
11.40
|
Cash Flow per Share
2 |
3.280
|
2.830
|
4.120
|
2.070
|
2.460
|
2.800
|
Capex
1 |
309
|
316
|
210
|
153
|
141
|
134
|
Capex / Sales
|
8.94%
|
9.73%
|
7.62%
|
5.37%
|
4.69%
|
6.11%
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/25/21
|
3/30/22
|
3/25/23
|
3/13/24
|
|
1st Jan change
|
Capi.
|
---|
| -7.84% | 79.91M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|